Biogen : BIIB

All Biogen Articles

606 Articles

Jon C. Ogg | Feb 3, 2020 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta…

Jon C. Ogg | Jan 30, 2020 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, Penn, McDonald’s, Microsoft, Tesla and More

Thursday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, McDonald's, Microsoft and Tesla.

Chris Lange | Jan 28, 2020 at 8:45 AM EST

Short Sellers Wary on Major Biotechs

The January 15 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Jan 27, 2020 at 1:55 PM EST

Why Biogen Could Become the King of Alzheimer’s Disease Treatment

If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology…

Chris Lange | Jan 27, 2020 at 11:30 AM EST

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

These three health care companies included are expected to report their earnings on Tuesday morning.

Jon C. Ogg | Jan 27, 2020 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge, Wynn and More

Monday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge Technologies and…

Chris Lange | Jan 26, 2020 at 7:10 AM EST

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and…

Chris Lange | Jan 13, 2020 at 8:40 AM EST

Major Biotechs Have Short Sellers Excited

The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Chris Lange | Dec 26, 2019 at 8:40 AM EST

Major Biotechs See Rising Short Interest

The December 13 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Dec 13, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle,…

Chris Lange | Dec 11, 2019 at 9:10 AM EST

Major Biotechs See a Rising Tide in Short Interest

The November 29 short interest data has been compared with the previous report, and short interest in most of these…

Jon C. Ogg | Dec 2, 2019 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: ADT, Altria, Biogen, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku, Schwab, Wells Fargo and More

Monday's top analyst upgrades, downgrades and initiations included ADT, Altria, Biogen, Charles Schwab, Chewy, Deere, Dollar Tree, eBay, Intel, Nike,…

Chris Lange | Nov 29, 2019 at 10:40 AM EST

Major Biopharma Catalysts on the December FDA Calendar

Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Nov 27, 2019 at 8:40 AM EST

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data…

Chris Lange | Nov 12, 2019 at 10:00 AM EST

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data…

1 … 6 7 8 9 10 … 41

Biogen : BIIB

All Biogen Articles

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Top Analyst Upgrades and Downgrades: Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, Penn, McDonald’s, Microsoft, Tesla and More

Short Sellers Wary on Major Biotechs

Why Biogen Could Become the King of Alzheimer’s Disease Treatment

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge, Wynn and More

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

Major Biotechs Have Short Sellers Excited

Major Biotechs See Rising Short Interest

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Major Biotechs See a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: ADT, Altria, Biogen, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku, Schwab, Wells Fargo and More

Major Biopharma Catalysts on the December FDA Calendar

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Biogen : BIIB

All Biogen Articles

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Top Analyst Upgrades and Downgrades: Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, Penn, McDonald’s, Microsoft, Tesla and More

Short Sellers Wary on Major Biotechs

Why Biogen Could Become the King of Alzheimer’s Disease Treatment

What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge, Wynn and More

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

Major Biotechs Have Short Sellers Excited

Major Biotechs See Rising Short Interest

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Major Biotechs See a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: ADT, Altria, Biogen, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku, Schwab, Wells Fargo and More

Major Biopharma Catalysts on the December FDA Calendar

Short Sellers Run For Cover From Major Biotechs

Major Biotechs See Rising Tide in Short Interest

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do